FDA Inspection
Cosette Pharmaceuticals, Inc.Cosette Pharmaceuticals, Inc. – FDA Inspection, Nov 15, 2024
Record Details
This FDA Inspection record concerns Cosette Pharmaceuticals, Inc., with an inspection on November 15, 2024, issued by the New Jersey District Office, covering human drugs.
- People
- Li-Hong P. Yeh (Issuing Officer)
- Nicola M. Fenty-Stewart (Issuing Officer)
View Company Profile
ID · dbc46977-8f13-4c7f-b75c-4d05f8488f5c
Inspection Facts
- Inspection number
- 1264195
- FDA center
- Human Drugs
Other FDA inspections of Cosette Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 29, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 15, 2018 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| January 26, 2017 | NAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| November 19, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cosette Pharmaceuticals, Inc.
- FDA Inspection 1230559 - 2024-01-25
- FDA Inspection 1047980 - 2018-03-29
- FDA Inspection 1041164 - 2018-02-15
- FDA Inspection 1009132 - 2017-01-26
- FDA Inspection 854338 - 2013-11-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.